Participant flow

Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer · Source last updated 2016-08-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Patients receive 1 capsule of placebo 2 times per day for 6 weeks and; patients receive 1 capsule of placebo 4 times per day for 6 weeks.

   id

   FG000

   title

   Collective Placebo

2. description

   Patients receive 5mg of Pilocarpine 2 times per day for 6 weeks.

   id

   FG001

   title

   Pilocarpine 2 Times Per Day

3. description

   Patients receive 5mg of Pilocarpine 4 times per day for 6 weeks.

   id

   FG002

   title

   Pilocarpine 4 Times Per Day

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         2

      2. group Id

         FG001

         num Subjects

         10

      3. group Id

         FG002

         num Subjects

         7

      type

      Adverse Event

   2. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         2

      3. group Id

         FG002

         num Subjects

         6

      type

      Withdrawal by Subject

   3. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         2

      3. group Id

         FG002

         num Subjects

         4

      type

      Other Reason Not Specified

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         64

      2. group Id

         FG001

         num Subjects

         65

      3. group Id

         FG002

         num Subjects

         66

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         60

      2. group Id

         FG001

         num Subjects

         51

      3. group Id

         FG002

         num Subjects

         49

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         4

      2. group Id

         FG001

         num Subjects

         14

      3. group Id

         FG002

         num Subjects

         17

      type

      NOT COMPLETED

   title

   Overall Study

pre Assignment Details

Five participants (2 collective placebo, 2 Pilocarpine 2 times per day, 1 Pilocarpine 4 times per day) canceled prior to study medication begins and one Pilocarpine 2 times per day participant was ineligible. These six participants were excluded from all analysis.

recruitment Details

Two-hundred and one (201) participants were recruited between December 2006 and May 2009 from 22 North Central Cancer Treatment Group (NCCTG) member sites.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice